Viveve Medical (VIVE) Reaches $7.49 After 4.00% Up Move; Valinor Management Has Lowered By $3.71 Million Its Jd Com (JD) Holding

May 19, 2017 - By Stephen Andrade

The stock of Viveve Medical Inc (NASDAQ:VIVE) is a huge mover today! About 56,573 shares traded. Viveve Medical Inc (NASDAQ:VIVE) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.The move comes after 9 months positive chart setup for the $147.63M company. It was reported on May, 19 by Barchart.com. We have $7.79 PT which if reached, will make NASDAQ:VIVE worth $5.91 million more.

Valinor Management Llc decreased Jd Com Inc (JD) stake by 3.82% reported in 2016Q4 SEC filing. Valinor Management Llc sold 148,300 shares as Jd Com Inc (JD)’s stock 0.00%. The Valinor Management Llc holds 3.74 million shares with $95.12 million value, down from 3.89 million last quarter. Jd Com Inc now has $58.92 billion valuation. The stock rose 2.41% or $0.97 reaching $41.13. About 4.97 million shares traded. JD.Com Inc(ADR) (NASDAQ:JD) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Valinor Management Llc increased Liberty Broadband Corp stake by 325,168 shares to 988,359 valued at $73.21 million in 2016Q4. It also upped Constellation Brands Inc (NYSE:STZ) stake by 152,300 shares and now owns 1.45 million shares. Air Prods & Chems Inc (NYSE:APD) was raised too.

Among 16 analysts covering JD.com (NASDAQ:JD), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. JD.com had 24 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of JD.Com Inc(ADR) (NASDAQ:JD) earned “Neutral” rating by JP Morgan on Wednesday, August 31. The firm has “Underperform” rating by Bernstein given on Wednesday, January 11. The stock has “Buy” rating by Goldman Sachs on Friday, November 6. The stock has “Buy” rating by M Partners on Tuesday, December 15. The stock of JD.Com Inc(ADR) (NASDAQ:JD) earned “Buy” rating by HSBC on Tuesday, November 10. Macquarie Research maintained the stock with “Outperform” rating in Tuesday, August 11 report. The firm has “Overweight” rating by Morgan Stanley given on Thursday, December 17. Bank of America maintained the stock with “Neutral” rating in Thursday, August 11 report. TH Capital initiated JD.Com Inc(ADR) (NASDAQ:JD) on Tuesday, August 4 with “Buy” rating. Morgan Stanley downgraded JD.Com Inc(ADR) (NASDAQ:JD) on Monday, August 10 to “Overweight” rating.

Viveve Medical, Inc. designs, develops, makes and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The company has market cap of $147.63 million. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System , generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. It currently has negative earnings. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console.